EN / 中文

Reduce immunosuppression within TME

Projects Indication Discovery & Lead Selection IND-enabling FIH Ownership

LTZ-121

Pan solid tumor

    Global
这里是上面的产品描述

LTZ-122

Pan solid tumor

    Global
这里是上面的产品描述

Activate/Re-program Innate Immunity

Projects Indication Discovery & Lead Selection IND-enabling FIH Ownership

LTZ-231

AML
    Global
这里是上面的产品描述

LTZ-232

Pan solid tumor

    Global
这里是上面的产品描述

Modulate Adaptive Immunity

Projects Indication Discovery & Lead Selection IND-enabling FIH Ownership

LTZ-301

NHL, FL, CLL
    Global
这里是上面的产品描述